Every Form 4 that ESAB Corp (ESAB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ESAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ESAB filings page.
Biebuyck Olivier reported acquisition or exercise transactions in this Form 4 filing.
ESAB Corp President, Fab Tech, Olivier Biebuyck reported equity awards consisting of restricted stock units and stock options. He received 2,152 restricted stock units, each representing one ESAB common share, and 7,475 employee stock options, both granted at a price of $0.00 per unit.
The restricted stock units vest in three equal annual installments on the first day of the month following each of the first, second, and third anniversaries of the grant date. The stock options vest and become exercisable on a similar three-year schedule, also in equal annual installments starting after the first anniversary.
ESAB Corp Chief Human Resources Officer Michele Campion reported the vesting of 633 restricted stock units, which were converted into an equal number of ESAB common shares on February 23, 2026. Each restricted stock unit represents a right to receive one ESAB common share.
To cover related tax obligations, 250 common shares were withheld by ESAB at $122.65 per share, as a tax-withholding disposition, and were not sold by Campion. After these transactions, she directly owned 13,393 ESAB common shares. The RSU award vests in three equal annual installments, with the remaining restricted stock units scheduled to vest on February 22, 2027.
ESAB Corp officer Renato Negro reported equity compensation activity. On February 23, 2026, 678 restricted stock units converted into 678 shares of common stock. To cover withholding taxes on this vesting, 268 shares were withheld by ESAB at $122.6500 per share, leaving him with 8,509 directly owned shares.
ESAB Corp President and CEO Shyam Kambeyanda reported a mix of option exercises, restricted stock unit activity, and share sales. On February 23, 2026, he exercised employee stock options covering 59,404 shares of common stock at $33.49 per share and converted 4,466 restricted stock units into common shares.
He then sold 59,404 common shares in open-market transactions at weighted-average prices ranging from $122.460 to $128.950 per share under a previously adopted Rule 10b5-1 trading plan. Following these transactions, he directly owns 102,239 shares of common stock and 4,467 restricted stock units. A total of 2,091 shares were withheld to satisfy tax obligations related to the vesting of restricted stock units.
ESAB Corp SVP and General Counsel Curtis E. Jewell reported equity compensation activity involving restricted stock units and common shares. On February 23, 2026, 693 restricted stock units were exercised or converted into 693 shares of ESAB common stock at a stated price of $0.00 per share.
To cover tax obligations from the vesting of these units, 327 common shares were withheld by ESAB at $122.65 per share, and no shares were sold by Jewell. After these transactions, he directly held 15,992 shares of common stock and 694 restricted stock units, with an additional 355.835 shares held indirectly through a 401(k) plan.
ESAB Corp Chief Financial Officer Kevin J. Johnson reported equity award activity involving restricted stock units and common shares. On February 23, 2026, he acquired 1,396 restricted stock units, each representing a contingent right to one ESAB common share.
The same day, he acquired 1,396 shares of common stock through an exercise or conversion of derivative securities, bringing his direct common stock holdings to 27,800 shares before tax withholding. ESAB then withheld 687 shares at $122.65 per share to satisfy tax liabilities upon RSU vesting, leaving him with 27,113 directly owned shares. The filing notes that no shares were sold by Johnson to cover these taxes.
ESAB Corp executive Olivier Biebuyck, President of Fab Tech, reported equity award activity involving restricted stock units and common shares. He exercised or converted 931 restricted stock units into 931 shares of common stock at a stated price of $0.0000 per share. To cover taxes on the vesting, 433 common shares were withheld by ESAB at a price of $122.65 per share, with no shares sold by Biebuyck in the market. After these transactions, he directly owned 15,452 common shares of ESAB.
ESAB Corp Chief Financial Officer Kevin J. Johnson reported several equity transactions in ESAB common stock. On February 6, 2026, he exercised an employee stock option for 9,139 shares at an exercise price of $33.49 per share, converting the option into common stock.
To cover the related tax liability and exercise price, 5,645 shares were withheld by ESAB at a price of $135.00 per share, rather than being sold in the market. Johnson also sold 3,494 shares of common stock at $134.62 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he directly owned 26,404 shares of ESAB common stock.
ESAB Corporation executive Olivier Biebuyck, President of Fab Tech, reported routine equity compensation activity. On February 2, 2026, 1,232 restricted stock units were converted into the same number of ESAB common shares as they vested.
To cover related tax obligations, 627 shares were withheld by ESAB at a price of $114.62 per share, with no shares sold by Biebuyck on the market. Following these transactions, he directly holds 14,954 shares of ESAB common stock.
ESAB Corp SVP and General Counsel Curtis E. Jewell reported an employee stock option exercise and related tax withholding. On January 26, 2026, he exercised options for 3,960 shares of common stock at $33.49 per share. ESAB withheld 2,512 shares at $120.475 per share to cover the exercise price and associated tax liability, and no shares were sold into the market for this purpose. After these transactions, Jewell directly owned 15,626 shares of ESAB common stock and indirectly held 354.75 shares through a 401(k) plan.
ESAB Corp director Martin Sebastien reported new equity awards. On January 1, 2026, he was granted 231 restricted stock units (RSUs), each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in a single installment on January 1, 2027, meaning the shares are deliverable only if he remains eligible through that date.
On the same date, he was also granted 777 stock options to purchase ESAB common stock at an exercise price of $112.57 per share. The filing states that these options vested and became exercisable in full on the grant date. Following these transactions, Sebastien directly holds 231 RSUs and 777 stock options as reported derivative securities.
ESAB Corp reported an equity transaction by its Chief Financial Officer on January 2, 2026. The filing shows that 986 restricted stock units (RSUs) were converted into an equal number of shares of ESAB common stock, reflecting the vesting of a prior equity award. In connection with this vesting, 537 shares of common stock were withheld by ESAB to cover the officer's tax liability at a price of $112.57 per share, and no shares were sold by the officer for this purpose.
After these transactions, the officer directly beneficially owned 26,404 shares of ESAB common stock. The RSU award referenced in the filing vests in three equal annual installments that began on January 2, 2025, with the remaining restricted stock units scheduled to vest on January 2, 2027.
ESAB Corp reported that one of its directors received 213 deferred stock units on 12/31/2025. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of the director's cash retainer for Board service, so they carry a price of $0 for this grant.
The deferred stock units vest immediately, meaning the director's right to the units is not subject to additional service conditions. However, the units will be settled in ESAB common stock only after the director separates from the company, aligning the director's compensation with the long‑term value of the stock.
ESAB Corp reported a routine equity compensation move for one of its directors. On 12/31/2025, the director received 263 deferred stock units, each representing a contingent right to receive one share of ESAB common stock. These units were issued in lieu of the director's cash retainer for Board service, effectively paying board fees in stock-based form rather than cash.
The deferred stock units vest immediately, but will only be settled in ESAB common stock after the director separates from the company. This structure aligns the director’s compensation with long-term shareholder value while deferring actual share delivery until service on the Board ends.
ESAB Corp reported that one of its directors received an equity-based award tied to board service. On 12/31/2025, the director was granted 54 deferred stock units, each representing the right to receive one share of ESAB common stock. These units were issued in lieu of the director’s cash retainer for serving on the Board.
The deferred stock units vest immediately, meaning they are fully earned on the grant date, but will be settled in ESAB common stock only after the director separates from the company. This aligns the director’s compensation more closely with ESAB’s long-term share performance without involving any open-market stock purchase or sale.
ESAB Corp reported that one of its directors received equity-based compensation in the form of deferred stock units. On 12/31/2025, the director acquired 213 deferred stock units, each representing a contingent right to receive one share of ESAB common stock with a par value of $0.001 per share.
These 213 deferred stock units were issued in lieu of the director's cash retainer for Board service, meaning the director chose stock-based pay instead of cash. The units vest immediately but will be settled in ESAB common stock only after the director separates from the company, aligning part of the director's compensation with long-term shareholder interests.
ESAB Corp director Mitchell P. Rales reported a grant of 493 shares of common stock in the form of deferred stock units on December 31, 2025, at a price of $0.00 per share. These units are payable only in common stock and will be settled after he leaves the Board, at the earlier of his death or January 31 of the second calendar year following his retirement.
After this grant, he directly holds 14,453 ESAB common shares. He also reports indirect holdings, including 3,355,765 shares through a single-member LLC, 4,816-share custodial accounts for his daughter for which he disclaims beneficial ownership, and 226,421 shares held by the Mitchell P. Rales Family Trust.
ESAB Corp reported an insider stock transaction on a Form 4 by one reporting person who serves as Officer, President, Fab Tech. On 12/15/2025, the insider reported two non-derivative transactions in ESAB common stock, each labeled with transaction code "G". Each transaction involved the disposition of 320 shares of common stock at a reported price of $0 per share. Following these transactions, the filing shows directly owned common stock holdings of 14,669 shares in one line and 14,349 shares in another line.
ESAB Corp reported a routine insider equity transaction by its Controller and PAO. On 11/24/2025, 205 restricted stock units converted into the same number of shares of common stock. To cover related tax obligations, 71 shares of common stock were withheld by ESAB Corporation at a price of $107.35 per share, and no shares were sold by the insider in the market.
After these transactions, the reporting person directly owned 8,099 shares of ESAB common stock. The underlying restricted stock unit award, which vested in three equal annual installments beginning on 11/22/2023, was fully vested as of 11/22/2025, leaving no derivative securities from this grant outstanding.
ESAB Corp (ESAB) — Form 4 insider activity: A director reported routine transactions. On 07/18/2025, 6.848 shares of common stock were acquired via dividend reinvestment at $127.56 per share. On 11/11/2025, the director exercised 2,783 stock options at $33.02 and sold 2,783 shares at $114.50. Following these transactions, directly owned common shares were 8,741.91.
Mitchell P. Rales, a director of ESAB Corp (ESAB), received 493 deferred stock units (DSUs) on 09/30/2025 that are payable solely in common stock and reported at a $0.00 price. The DSUs will convert into shares upon the earlier of his death or January 31 of the second calendar year after his retirement from the board. Following the grant, the filing reports Mr. Rales' beneficial holdings as 13,960 shares directly and substantial indirect holdings including 3,355,765 shares held through a single-member LLC, 226,421 shares held by the Mitchell P. Rales Family Trust, and two custodial trust entries of 4,816 shares each for his daughter, which he disclaims beneficial ownership of. The Form 4 was signed on 10/02/2025.
Stephanie M. Phillipps, a director of ESAB Corp (ESAB), was granted 54 deferred stock units on 09/30/2025 as compensation for board service. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of the director's cash retainer, vest immediately, and will be settled in common stock after the director's separation from the company. Following the reported transaction, the reporting person beneficially owns 54 shares. The Form 4 was signed by an attorney-in-fact on 10/01/2025.
ESAB director Patrick W. Allender was issued 213 deferred stock units (DSUs) on 09/30/2025. Each DSU represents a contingent right to one share of ESAB common stock and the units were issued in lieu of the director's cash retainer for Board service. The DSUs vest immediately and will be settled in ESAB common stock after the director separates from the company. The reported transaction shows 0 purchase price and leaves Mr. Allender with 213 shares (or share equivalents) beneficially owned following the issuance. The Form 4 was signed by an Attorney-in-Fact on behalf of the reporting person on 10/01/2025.